Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 0 | 165 | 0 | 0 | 0 |
| Gross Profit | N/A | 165 | N/A | N/A | N/A |
| Operating Expenses | 3,448 | 3,141 | 3,351 | 3,126 | 3,171 |
| Operating Income | -3,448 | -2,976 | -3,351 | -3,126 | -3,171 |
| Interest Expense | 155 | 184 | 205 | 224 | 0 |
| Other Income | 311 | 99 | 125 | 125 | -54 |
| Pre-tax Income | -3,292 | -3,060 | -3,431 | -3,224 | -3,226 |
| Income Tax | 0 | N/A | N/A | 0 | 1 |
| Net Income Continuous | -3,292 | -3,060 | -3,431 | -3,225 | -3,227 |
| Net Income | $-3,292 | $-3,060 | $-3,431 | $-3,225 | $-3,227 |
| EPS Basic Total Ops | -1.70 | -2.04 | -2.38 | -2.38 | -2.55 |
| EPS Basic Continuous Ops | -1.74 | -2.09 | -2.37 | -2.35 | -2.54 |
| EPS Diluted Total Ops | -1.70 | -2.04 | -2.38 | -2.38 | -2.55 |
| EPS Diluted Continuous Ops | -1.74 | -2.09 | -2.37 | -2.35 | -2.54 |
| EBITDA(a) | $-3,461 | $-3,014 | $-3,410 | $-3,164 | $-3,206 |